Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2443622rdf:typepubmed:Citationlld:pubmed
pubmed-article:2443622lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0029925lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0281548lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:2443622lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:2443622pubmed:issue10lld:pubmed
pubmed-article:2443622pubmed:dateCreated1987-11-6lld:pubmed
pubmed-article:2443622pubmed:abstractTextNinety ovarian carcinoma patients failing primary intravenous (IV) combination chemotherapy were treated with cisplatin-based combination intraperitoneal therapy. Sixty-five patients had residual disease greater than 2 cm at the start of intraperitoneal therapy. Their median survival was 8 months. Twenty-five patients had disease less than 2 cm; their median survival was greater than 49 months, and the survival curve has an apparent plateau at 69%, with no relapses having occurred after 32 months. The median survival for all 90 patients was 15 months. The median duration of follow-up for all patients was 37 months. These results confirm the critical role of tumor bulk in determining the effectiveness of intraperitoneal therapy, and suggest a role for intraperitoneal salvage treatment in patients with small-volume disease.lld:pubmed
pubmed-article:2443622pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:languageenglld:pubmed
pubmed-article:2443622pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:citationSubsetIMlld:pubmed
pubmed-article:2443622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2443622pubmed:statusMEDLINElld:pubmed
pubmed-article:2443622pubmed:monthOctlld:pubmed
pubmed-article:2443622pubmed:issn0732-183Xlld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:LucasW EWElld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:WeissR JRJlld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:HowellS BSBlld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:MarkmanMMlld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:ZimmSSlld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:AbramsonI SISlld:pubmed
pubmed-article:2443622pubmed:authorpubmed-author:ClearySSlld:pubmed
pubmed-article:2443622pubmed:issnTypePrintlld:pubmed
pubmed-article:2443622pubmed:volume5lld:pubmed
pubmed-article:2443622pubmed:ownerNLMlld:pubmed
pubmed-article:2443622pubmed:authorsCompleteYlld:pubmed
pubmed-article:2443622pubmed:pagination1607-12lld:pubmed
pubmed-article:2443622pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:meshHeadingpubmed-meshheading:2443622-...lld:pubmed
pubmed-article:2443622pubmed:year1987lld:pubmed
pubmed-article:2443622pubmed:articleTitleLong-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.lld:pubmed
pubmed-article:2443622pubmed:affiliationDepartment of Medicine, University of California, San Diego, La Jolla 92093.lld:pubmed
pubmed-article:2443622pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2443622pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2443622pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2443622pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2443622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2443622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2443622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2443622lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2443622lld:pubmed